The combination of dehydroepiandrosterone, transdermal testosterone, and growth hormone as an adjuvant therapy in assisted reproductive technology cycles in patients aged below 40 years with diminished ovarian reserve

OBJECTIVE: To evaluate to the efficacy of testosterone, dehydroepiandrosterone (DHEA) and growth hormone (GH) supplementations in patients with diminished ovarian reserve (DOR) in assisted reproductive technology (ART) cycles. MATERIALS AND METHODS: A retrospective cohort including 33 women with 81...

Descripción completa

Detalles Bibliográficos
Autores principales: Haydardedeoğlu, Bülent, Işık, Ahmet Zeki, Bulgan Kılıçdağ, Esra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2015
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558377/
https://www.ncbi.nlm.nih.gov/pubmed/28913044
http://dx.doi.org/10.4274/tjod.32656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558377/
https://www.ncbi.nlm.nih.gov/pubmed/28913044
http://dx.doi.org/10.4274/tjod.32656

Ejemplares similares